HARVARD BIOSCIENCE INC — Director's Dealing 2020

Nov 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2020-11-01

Reporting Person: Olson Kenneth Fletcher (Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-01	Common Stock	D	1863	$0.00	Disposed	88598	Direct
2020-11-01	Common Stock	F	1806	$3.46	Disposed	86792	Direct

Footnotes

F1: On November 1, 2019, the Reporting Person was granted an award of 16,949 restricted stock units with performance based vesting conditions based on the achievement of a relative total shareholder return of the Issuer's common stock from November 1, 2019 to the earlier of (i) November 1, 2020 or (ii) upon a change of control (measured relative to the NASDAQ Biotechnology index). The target number of the restricted stock units that may be earned was reported on the date of grant; the maximum amount is 150% of the number then reported. As a result of the Issuer's performance based on such performance targets, the reporting person earned 89% of the target amount, subject to continuation of employment through the remaining vesting dates. Accordingly, the reported transaction reflects the reduction of 1,863 performance restricted stock units from the target grant amount.

F2: Includes (a) the award described in footnote (1) above, (b) 36,756 restricted stock units that will vest on December 31, 2020, 2021, 2022 and 2023; and (c) 36,756 restricted stock units with performance based vesting conditions tied to relative total shareholder return.

F3: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a performance restricted stock unit award previously granted to the Reporting Person that vested in part on November 1, 2020.

F4: Includes (a) the shares and awards described in footnote (2) above, less (b) the disposition of shares reported in footnote (3) above.